Contrast sensitivity function in patients with beta-thalassemia major

Acta Ophthalmologica Scandinavica

Volumn 78, Issue 5, 2000, Pages 512-515

  Gartaganis, Sotirios P ^a   Zoumbos, Nikolaos ^a   Koliopoulos, John X ^a   Mela, Ephigenia K ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Beta thalassemia; Blood transfusion; Chelation therapy; Contrast sensitivity; Deferoxamine; Ferritin; Retinal pigmentary changes

Indexed keywords

DEFEROXAMINE; FERRITIN;

ADOLESCENT; ADULT; AGE; ARTICLE; BETA THALASSEMIA; CHELATION THERAPY; CLINICAL ARTICLE; CONTRAST SENSITIVITY; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; FLUORESCENCE ANGIOGRAPHY; HUMAN; LONG TERM CARE; MALE; PATIENT MONITORING; PRIORITY JOURNAL; SPATIAL FREQUENCY DISCRIMINATION; THALASSEMIA MAJOR; TRANSFUSION; VISION; VISUAL SYSTEM EXAMINATION;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHELATION THERAPY; CONTRAST SENSITIVITY; DEFEROXAMINE; FEMALE; FERRITINS; FLUORESCEIN ANGIOGRAPHY; HUMANS; MALE; MIDDLE AGED; VISION DISORDERS;

EID: 0033828836     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.2000.078005512.x     Document Type: Article

References (26)

1. Ocular changes in patients undergoing long-term desferrioxamine treatment
2. Lens opacities in thalassemia
3. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major
4. Ocular toxicity of high-dose intravenous desferrioxamine
5. Ocular findings in Desferal therapy
6. Ophthalmoscopic changes in a patient with Wilson's disease during long-term penicillamine therapy
7. Spatial contrast sensitivity of myopic subjects
8. Ocular abnormalities in patients with b-thalassemia
9. Electroretinographic and visual-evoked potential abnormalities in patients with beta-thalassemia major
10. Histochemical localization of zinc and copper in rat ocular tissues
11. Deferoxamine (Desferal)-induced toxic retinal pigmentary degeneration and presumed optic neuropathy
12. The effect of severe zinc deficiency on the morphology of the rat retinal pigment epithelium
13. Food and Drug Administration study update. One-year results from 671 patients with the 3M multifocal intraocular lens
14. Electrophysiological consequence of retinal hypoxia
15. Contrast sensitivity function after cataract extraction and intraocular lens implantation
16. Advances in the use of iron-chelating agents for the treatment of iron overload
17. Visual and auditory neurotoxicity in patients receiving subcutaneous desferrioxamine infusions
18. A risk-benefit assessment of iron-chelation therapy
19. Ocular toxicity of desferrioxamine: Light microscopic, histochemical and ultrastructural findings
20. Low-contrast letter charts as a test of visual function
21. Ocular involvement correlated with age in patients affected by major and intermedia β-thalassemia treated or not with desferrioxamine
22. Subclinical VEP abnormalities in patients on chronic deferoxamine therapy: Longitudinal studies
23. Distributions of elements in the human retinal pigment epithelium
24. Contrast sensitivity in retinal disease
25. Survival and causes of death in thalassemia major